ABIVAX press release
Ida Hatoum is appointed Human Resources Director of Abivax.
As Director of Human Resources, Ida Hatoum will lead the company’s organizational design strategy and its implementation, enabling the strengthening of the Abivax team in the United States and Europe, across all functions.
Ida has extensive experience in recruiting and developing talent in the biopharmaceutical industry.
Abivax SA, a Phase 3 clinical-stage biotechnology company developing immune-modulating drugs to treat patients with chronic inflammatory diseases, today announces the appointment of Ida Hatoum as Chief Human Resources Officer. Ida will be responsible for leading Abivax’s growth strategy in the United States as well as Europe, aimed at ensuring that the Company has the right personnel to complete its phase 3 clinical program of obefazimod in ulcerative colitis, as well as subsequently access to the market and marketing of its drug candidate, subject to obtaining the necessary regulatory authorizations. Ida will be based within the Abivax subsidiary established on the East Coast in the United States